FDA Approved: ASPIRIN AND EXTENDED - RELEASE DIPYRIDAMOLE CAPSULES, 25 MG / 200 MG — Original Application (Endo USA, Inc.)

View source ↗

Summary

FDA approves Endo USA's aspirin and extended-release dipyridamole capsules (25 mg/200 mg) for reducing the risk of stroke in patients who have had a transient i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Disease
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES, 25 MG / 200 MG (aspirin; dipyridamole (extended-release))

Snippet

ORIG AP for ASPIRIN AND EXTENDED - RELEASE DIPYRIDAMOLE CAPSULES, 25 MG / 200 MG (ASPIRIN AND EXTENDED - RELEASE DIPYRIDAMOLE)